Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2014

01-10-2014 | Review Article

Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review

Authors: Vivien Tong, David K. Raynor, Parisa Aslani

Published in: International Journal of Clinical Pharmacy | Issue 5/2014

Login to get access

Abstract

Background Over-the-counter medicines must be supplied with appropriate, user-friendly medicine information to satisfactorily support consumer self-management and safe use. Product labels and written medicine information leaflets are highly accessible over-the-counter medicine information sources for consumers. Factors such as comprehensibility and design underpin the usefulness of over-the-counter labels and leaflets and should be further examined to better inform future optimisation strategies. Aim of the review To undertake an in-depth exploration of studies that have evaluated design and/or comprehensibility of over-the-counter labels and written medicine information leaflets Methods Database searches were performed using Medline, Embase, International Pharmaceutical Abstracts and PubMed. Studies exploring over-the-counter medicine label and/or leaflet comprehensibility and/or design were identified. Additional author and reference list searches were performed to identify studies which met the inclusion criteria and key terms. Results A total of 35 studies were included in the review, which explored OTC medicine information design and/or comprehensibility via researcher evaluation alone (n = 8) or with consumers (n = 27). Researcher-determined over-the-counter written medicine information leaflet readability (n = 4) has highlighted suboptimal readability, with few studies evaluating over-the-counter leaflet performance using the gold standard method of ‘user testing’ with consumers (n = 2). Variable over-the-counter label comprehensibility was identified in consumer studies, ranging from satisfactory understanding to considerable misunderstanding. The review findings indicate that consumer outcomes were influenced by information design, where implementation of good design principles generally improved over-the-counter label and leaflet performance. Significant diversity existed in study design aspects such as sampling frames, sample sizes and tools used to evaluate over-the-counter medicine information, which hindered the ability to adequately compare various study aspects and findings. Conclusion A wide spectrum of consumer understanding of over-the-counter medicine labels is evident in the literature, with limited studies examining over-the-counter written medicine information leaflet comprehensibility with consumers. The application of good information design principles in over-the-counter labels and leaflets contribute to improved performance. Well-designed consumer studies are needed to ascertain and optimise over-the-counter label and leaflet performance.
Appendix
Available only for authorised users
Literature
1.
go back to reference Blom AT, Rens JA. Information about over-the-counter medication: the role of the pharmacy. Patient Educ Couns. 1989;14(3):181–9.PubMedCrossRef Blom AT, Rens JA. Information about over-the-counter medication: the role of the pharmacy. Patient Educ Couns. 1989;14(3):181–9.PubMedCrossRef
2.
go back to reference Newby DA, Hill SR, Barker BJ, Drew AK, Henry DA. Drug information for consumers: should it be disease or medication specific? Results of a community survey. Aust New Zeal J Publ Health. 2001;25(6):564–70.CrossRef Newby DA, Hill SR, Barker BJ, Drew AK, Henry DA. Drug information for consumers: should it be disease or medication specific? Results of a community survey. Aust New Zeal J Publ Health. 2001;25(6):564–70.CrossRef
3.
go back to reference Simoens S, Lobeau M, Verbeke K, van Aerschot A. Patient experiences of over-the-counter medicine purchases in Flemish community pharmacies. Pharm World Sci. 2009;31(4):450–7.PubMedCrossRef Simoens S, Lobeau M, Verbeke K, van Aerschot A. Patient experiences of over-the-counter medicine purchases in Flemish community pharmacies. Pharm World Sci. 2009;31(4):450–7.PubMedCrossRef
4.
go back to reference Gray NJ, Cantrill JA, Noyce PR. ‘Health repertories’: an understanding of lay management of minor ailments. Patient Educ Couns. 2002;47(3):237–44.PubMedCrossRef Gray NJ, Cantrill JA, Noyce PR. ‘Health repertories’: an understanding of lay management of minor ailments. Patient Educ Couns. 2002;47(3):237–44.PubMedCrossRef
5.
go back to reference Harris interactive for NCPIE (National Council on Patient Information and Education). Attitudes and beliefs about the use of over-the-counter medicines: a dose of reality; a national survey of consumers and health professionals; 2002. Harris interactive for NCPIE (National Council on Patient Information and Education). Attitudes and beliefs about the use of over-the-counter medicines: a dose of reality; a national survey of consumers and health professionals; 2002.
6.
go back to reference Birchley N, Conroy S. Parental management of over-the-counter medicines. Paediatr Nurs. 2002;14(9):24–8.PubMed Birchley N, Conroy S. Parental management of over-the-counter medicines. Paediatr Nurs. 2002;14(9):24–8.PubMed
7.
go back to reference Nabors LA, Lehmkuhl HD, Parkins IS, Drury AM. Reading about over-the-counter medications. Issues Compr Pediatr Nurs. 2004;27(4):297–305.PubMedCrossRef Nabors LA, Lehmkuhl HD, Parkins IS, Drury AM. Reading about over-the-counter medications. Issues Compr Pediatr Nurs. 2004;27(4):297–305.PubMedCrossRef
8.
go back to reference Over-the-counter human drugs; Labeling requirements; Final Rule (1999 Mar 17). Over-the-counter human drugs; Labeling requirements; Final Rule (1999 Mar 17).
9.
go back to reference Medicines and healthcare products regulatory agency committee on safety of medicines. Always read the leaflet: getting the best information with every medicine—report of the Committee on Safety of Medicines Working Group on Patient Information. London: The Stationery Office; 2005. Medicines and healthcare products regulatory agency committee on safety of medicines. Always read the leaflet: getting the best information with every medicine—report of the Committee on Safety of Medicines Working Group on Patient Information. London: The Stationery Office; 2005.
10.
go back to reference Australian Government Department of Health and Ageing Therapeutic Goods Administration. TGA medicine labelling and packaging review: Consultation Paper Version 1.0 May 2012. Australian Capital Territory: Commonwealth of Australia, 2012. Report number.:R12/759506. Australian Government Department of Health and Ageing Therapeutic Goods Administration. TGA medicine labelling and packaging review: Consultation Paper Version 1.0 May 2012. Australian Capital Territory: Commonwealth of Australia, 2012. Report number.:R12/759506.
11.
go back to reference Holt GA, Hollon JD, Hughes SE, Coyle R. OTC labels: can consumers read and understand them? Am Pharm. 1990;NS30(11):51–4.PubMed Holt GA, Hollon JD, Hughes SE, Coyle R. OTC labels: can consumers read and understand them? Am Pharm. 1990;NS30(11):51–4.PubMed
12.
go back to reference Auta A, Shalkur D, Dayom D, Banwat S. Readability of over-the-counter medicine information leaflets in Nigeria. IJPFR. 2011;1(2):61–7. Auta A, Shalkur D, Dayom D, Banwat S. Readability of over-the-counter medicine information leaflets in Nigeria. IJPFR. 2011;1(2):61–7.
13.
go back to reference Bradley B, Singleton M, Li Wan Po A. Readability of patient information leaflets on over-the-counter (OTC) medicines. J Clin Pharm Ther. 1994;19(1):7–15.PubMedCrossRef Bradley B, Singleton M, Li Wan Po A. Readability of patient information leaflets on over-the-counter (OTC) medicines. J Clin Pharm Ther. 1994;19(1):7–15.PubMedCrossRef
14.
go back to reference El-Ibiary SY, Youmans SL. Health literacy and contraception: a readability evaluation of contraceptive instructions for condoms, spermicides and emergency contraception in the USA. Eur J Contracept Reprod Health Care. 2007;12(1):58–62.PubMedCrossRef El-Ibiary SY, Youmans SL. Health literacy and contraception: a readability evaluation of contraceptive instructions for condoms, spermicides and emergency contraception in the USA. Eur J Contracept Reprod Health Care. 2007;12(1):58–62.PubMedCrossRef
15.
go back to reference Stevens AB, McDaniel KS, Glover ED, Wallace LS. Are instructions for over-the-counter nicotine replacement therapy products readable? Am J Health Behav. 2007;31(Suppl 1):S79–84.PubMedCrossRef Stevens AB, McDaniel KS, Glover ED, Wallace LS. Are instructions for over-the-counter nicotine replacement therapy products readable? Am J Health Behav. 2007;31(Suppl 1):S79–84.PubMedCrossRef
16.
go back to reference Sansgiry SS, Cady PS, Patil S. Readability of over-the-counter medication labels. J Am Pharm Assoc. 1997;NS37(5):522–8. Sansgiry SS, Cady PS, Patil S. Readability of over-the-counter medication labels. J Am Pharm Assoc. 1997;NS37(5):522–8.
17.
go back to reference Sansgiry SS, Shringarpure G. Manufacturers’ compliance with the US Food and Drug Administration’s over-the-counter human drugs: labeling requirements. Packag Technol Sci. 2003;16(3):91–8.CrossRef Sansgiry SS, Shringarpure G. Manufacturers’ compliance with the US Food and Drug Administration’s over-the-counter human drugs: labeling requirements. Packag Technol Sci. 2003;16(3):91–8.CrossRef
18.
go back to reference Twomey C. An analysis of patient information leaflets supplied with medicines sold by pharmacists in the United Kingdom. Library and Information Research News. 2001;25(80):3–12. Twomey C. An analysis of patient information leaflets supplied with medicines sold by pharmacists in the United Kingdom. Library and Information Research News. 2001;25(80):3–12.
19.
go back to reference Brass EP, Vassil T, Replogle A, Hwang P, Rusche S, Shiffman S, et al. Can consumers self-select for appropriate use of an over-the-counter statin? The self evaluation of lovastatin to enhance cholesterol treatment study. Am J Cardiol. 2008;101(10):1448–55.PubMedCrossRef Brass EP, Vassil T, Replogle A, Hwang P, Rusche S, Shiffman S, et al. Can consumers self-select for appropriate use of an over-the-counter statin? The self evaluation of lovastatin to enhance cholesterol treatment study. Am J Cardiol. 2008;101(10):1448–55.PubMedCrossRef
20.
go back to reference Catlin JR, Pechmann C, Brass EP. The influence of need for cognition and principal display panel factors on over-the-counter Drug Facts label comprehension. Health Commun. 2012;27(3):264–72.PubMedCrossRef Catlin JR, Pechmann C, Brass EP. The influence of need for cognition and principal display panel factors on over-the-counter Drug Facts label comprehension. Health Commun. 2012;27(3):264–72.PubMedCrossRef
21.
go back to reference Ciociola AA, Sirgo MA, Pappa KA, McGuire JA, Fung K. A study of the nonprescription drug consumer’s understanding of the ranitidine product label and actual product usage patterns in the treatment of episodic heartburn. Am J Ther. 2001;8(6):387–98.PubMedCrossRef Ciociola AA, Sirgo MA, Pappa KA, McGuire JA, Fung K. A study of the nonprescription drug consumer’s understanding of the ranitidine product label and actual product usage patterns in the treatment of episodic heartburn. Am J Ther. 2001;8(6):387–98.PubMedCrossRef
22.
go back to reference Lokker N, Sanders L, Perrin EM, Kumar D, Finkle J, Franco V, et al. Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics. 2009;123(6):1464–71.PubMedCrossRefPubMedCentral Lokker N, Sanders L, Perrin EM, Kumar D, Finkle J, Franco V, et al. Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics. 2009;123(6):1464–71.PubMedCrossRefPubMedCentral
23.
go back to reference Patel VL, Branch T, Arocha JF. Errors in interpreting quantities as procedures: the case of pharmaceutical labels. Int J Med Inform. 2002;65(3):193–211.PubMedCrossRef Patel VL, Branch T, Arocha JF. Errors in interpreting quantities as procedures: the case of pharmaceutical labels. Int J Med Inform. 2002;65(3):193–211.PubMedCrossRef
24.
go back to reference Proprietary Medicines Association of Australia. Making medicine labels work: the impact of changing the design and content of labels. North Sydney: Proprietary Medicines Association of Australia; 1992. p. 12. Proprietary Medicines Association of Australia. Making medicine labels work: the impact of changing the design and content of labels. North Sydney: Proprietary Medicines Association of Australia; 1992. p. 12.
25.
go back to reference Raymond EG, Dalebout SM, Camp SI. Comprehension of a prototype over-the-counter label for an emergency contraceptive pill product. Obstet Gynecol. 2002;100(2):342–9.PubMedCrossRef Raymond EG, Dalebout SM, Camp SI. Comprehension of a prototype over-the-counter label for an emergency contraceptive pill product. Obstet Gynecol. 2002;100(2):342–9.PubMedCrossRef
26.
go back to reference Raymond EG, L’Engle KL, Tolley EE, Ricciotti N, Arnold MV, Park S. Comprehension of a prototype emergency contraception package label by female adolescents. Contraception. 2009;79(3):199–205.PubMedCrossRef Raymond EG, L’Engle KL, Tolley EE, Ricciotti N, Arnold MV, Park S. Comprehension of a prototype emergency contraception package label by female adolescents. Contraception. 2009;79(3):199–205.PubMedCrossRef
27.
go back to reference Rogers D, Shulman A, Sless D, Beach R. Designing better medicine labels: report to PHARM. Australia: Communication Research Institute of Australia; 1995 69 p. Rogers D, Shulman A, Sless D, Beach R. Designing better medicine labels: report to PHARM. Australia: Communication Research Institute of Australia; 1995 69 p.
28.
go back to reference Simon H, Weinkle D. Over-the-counter medications: do parents give what they intend to give? Arch Pediatr Adolesc Med. 1997;151(7):654–6.PubMedCrossRef Simon H, Weinkle D. Over-the-counter medications: do parents give what they intend to give? Arch Pediatr Adolesc Med. 1997;151(7):654–6.PubMedCrossRef
29.
go back to reference Sless D, Tyers A. Medicine labelling for consumers. Australia: Communication Research Institute of Australia. Sless D, Tyers A. Medicine labelling for consumers. Australia: Communication Research Institute of Australia.
30.
go back to reference Wilke T, Müller S, Neumann K, Loder T. Does package design matter for patients? The association between package design and patients’ drug knowledge. Pharm Med. 2011;25(5):307–17.CrossRef Wilke T, Müller S, Neumann K, Loder T. Does package design matter for patients? The association between package design and patients’ drug knowledge. Pharm Med. 2011;25(5):307–17.CrossRef
31.
go back to reference Wogalter MS, Vigilante WJ Jr. Effects of label format on knowledge acquisition and perceived readability by younger and older adults. Ergonomics. 2003;46(4):327–44.PubMedCrossRef Wogalter MS, Vigilante WJ Jr. Effects of label format on knowledge acquisition and perceived readability by younger and older adults. Ergonomics. 2003;46(4):327–44.PubMedCrossRef
32.
go back to reference Fuchs J, Hippius M. Inappropriate dosage instructions in package inserts. Patient Educ Couns. 2007;67(1–2):157–68.PubMedCrossRef Fuchs J, Hippius M. Inappropriate dosage instructions in package inserts. Patient Educ Couns. 2007;67(1–2):157–68.PubMedCrossRef
33.
go back to reference Lee I, Lee HW, Je NK, Lee S. Examining the readability of two package inserts for self-medication in South Korea. Pharmacoepidem Dr S. 2012;21(Suppl 3):214. Lee I, Lee HW, Je NK, Lee S. Examining the readability of two package inserts for self-medication in South Korea. Pharmacoepidem Dr S. 2012;21(Suppl 3):214.
34.
go back to reference Friedman CP, Romeo D, Hinton SS. Healthcare decisions and product labeling: results of a consumer comprehension study of prototype labeling for proposed over-the-counter cholestyramine. Am J Med. 1997;102(2A):50–6.PubMedCrossRef Friedman CP, Romeo D, Hinton SS. Healthcare decisions and product labeling: results of a consumer comprehension study of prototype labeling for proposed over-the-counter cholestyramine. Am J Med. 1997;102(2A):50–6.PubMedCrossRef
36.
go back to reference Hellier E, Tucker M, Kenny N, Rowntree A, Edworthy J. Merits of using color and shape differentiation to improve the speed and accuracy of drug strength identification on over-the-counter medicines by laypeople. J Patient Saf. 2010;6(3):158–64.PubMedCrossRef Hellier E, Tucker M, Kenny N, Rowntree A, Edworthy J. Merits of using color and shape differentiation to improve the speed and accuracy of drug strength identification on over-the-counter medicines by laypeople. J Patient Saf. 2010;6(3):158–64.PubMedCrossRef
37.
go back to reference Mendat CC, Watson AM, Mayhorn CB, Wogalter MS. Age differences in search time for two over-the-counter (OTC) drug label formats. Proc Hum Fact Ergon Soc Annu Meet. 2005;49(2):200–3.CrossRef Mendat CC, Watson AM, Mayhorn CB, Wogalter MS. Age differences in search time for two over-the-counter (OTC) drug label formats. Proc Hum Fact Ergon Soc Annu Meet. 2005;49(2):200–3.CrossRef
38.
go back to reference Murty S, Sansgiry SS. Consumer comprehension of OTC medication labels and the scope for improvement in font size. J Pharm Technol. 2007;23(4):207–13.CrossRef Murty S, Sansgiry SS. Consumer comprehension of OTC medication labels and the scope for improvement in font size. J Pharm Technol. 2007;23(4):207–13.CrossRef
39.
go back to reference Sansgiry SS, Cady PS. The effect of label content and placement on consumers’ understanding of OTC product label information. J Pharm Mark Manag. 1995;9(3):55–68.CrossRef Sansgiry SS, Cady PS. The effect of label content and placement on consumers’ understanding of OTC product label information. J Pharm Mark Manag. 1995;9(3):55–68.CrossRef
40.
go back to reference Sansgiry SS, Cady PS, Sansgiry S. Effect of package design on evaluation of OTC medication information. J Soc Adm Pharm. 2001;18(1):24–34. Sansgiry SS, Cady PS, Sansgiry S. Effect of package design on evaluation of OTC medication information. J Soc Adm Pharm. 2001;18(1):24–34.
41.
go back to reference Shaver EF, Wogalter MS. A comparison of older vs. newer over-the-counter (OTC) nonprescription drug labels on search time accuracy. Proc Hum Fact Ergon Soc. Annu Meet. 2003;47(5):826–30. Shaver EF, Wogalter MS. A comparison of older vs. newer over-the-counter (OTC) nonprescription drug labels on search time accuracy. Proc Hum Fact Ergon Soc. Annu Meet. 2003;47(5):826–30.
42.
go back to reference Watanabe RK, Gilbreath K, Sakamoto CC. The ability of the geriatric population to read labels on over-the-counter medication containers. J Am Optom Assoc. 1994;65(1):32–7.PubMed Watanabe RK, Gilbreath K, Sakamoto CC. The ability of the geriatric population to read labels on over-the-counter medication containers. J Am Optom Assoc. 1994;65(1):32–7.PubMed
43.
go back to reference Wogalter MS, Magurno AB, Scott KL, Dietrich DA. Facilitating information acquisition for over-the-counter drugs using supplemental labels. Proc Hum Fact Ergon Soc Annu Meet. 1996;40(14):732–6.CrossRef Wogalter MS, Magurno AB, Scott KL, Dietrich DA. Facilitating information acquisition for over-the-counter drugs using supplemental labels. Proc Hum Fact Ergon Soc Annu Meet. 1996;40(14):732–6.CrossRef
44.
go back to reference Aslani P, Hamrosi K, Feletto E, Raynor DK, Knapp P, Parkinson B et al. Investigating Consumer Medicine Information (I-CMI) project. Sydney: The Pharmacy Guild of Australia, Australian Government Department of Health and Ageing; 2010. Aslani P, Hamrosi K, Feletto E, Raynor DK, Knapp P, Parkinson B et al. Investigating Consumer Medicine Information (I-CMI) project. Sydney: The Pharmacy Guild of Australia, Australian Government Department of Health and Ageing; 2010.
45.
go back to reference Dickinson D, Raynor DK, Duman M. Patient information leaflets for medicines: using consumer testing to determine the most effective design. Patient Educ Couns. 2001;43(2):147–59.PubMedCrossRef Dickinson D, Raynor DK, Duman M. Patient information leaflets for medicines: using consumer testing to determine the most effective design. Patient Educ Couns. 2001;43(2):147–59.PubMedCrossRef
46.
go back to reference Sless D, Shrensky R. Writing about medicines for people: usability guidelines for consumer medicine information. 3rd ed. North Sydney: Australian Self Medication Industry; 2006. Sless D, Shrensky R. Writing about medicines for people: usability guidelines for consumer medicine information. 3rd ed. North Sydney: Australian Self Medication Industry; 2006.
48.
go back to reference Luk A, Aslani P. Tools used to evaluate written medicine and health information: document and user perspectives. Health Educ Behav. 2011;38(4):389–403.PubMedCrossRef Luk A, Aslani P. Tools used to evaluate written medicine and health information: document and user perspectives. Health Educ Behav. 2011;38(4):389–403.PubMedCrossRef
49.
go back to reference Hoar N, Hoar ME. Readability formulas: are they enough? Contemp Pharm Pract. 1981;4(3):145–9.PubMed Hoar N, Hoar ME. Readability formulas: are they enough? Contemp Pharm Pract. 1981;4(3):145–9.PubMed
50.
go back to reference Holt G, Dorcheus L, Hall E, Beck D, Ellis E, Hough J. Patient interpretation of label instructions. Am Pharm. 1992;NS32(3):58–62. Holt G, Dorcheus L, Hall E, Beck D, Ellis E, Hough J. Patient interpretation of label instructions. Am Pharm. 1992;NS32(3):58–62.
51.
go back to reference Wolf MS, Davis TC, Shrank W, Rapp DN, Bass PF, Connor UM, et al. To err is human: patient misinterpretations of prescription drug label instructions. Patient Educ Couns. 2007;67(3):293–300.PubMedCrossRef Wolf MS, Davis TC, Shrank W, Rapp DN, Bass PF, Connor UM, et al. To err is human: patient misinterpretations of prescription drug label instructions. Patient Educ Couns. 2007;67(3):293–300.PubMedCrossRef
52.
go back to reference Davis TC, Federman AD, Bass PF, Jackson RH, Middlebrooks M, Parker RM, et al. Improving patient understanding of prescription drug label instructions. J Gen Intern Med. 2009;24(1):57–62.PubMedCrossRefPubMedCentral Davis TC, Federman AD, Bass PF, Jackson RH, Middlebrooks M, Parker RM, et al. Improving patient understanding of prescription drug label instructions. J Gen Intern Med. 2009;24(1):57–62.PubMedCrossRefPubMedCentral
53.
go back to reference Davis TC, Wolf MS, Bass PF 3rd, Thompson JA, Tilson HH, Neuberger M, et al. Literacy and misunderstanding prescription drug labels. Ann Intern Med. 2006;145(12):887–94.PubMedCrossRef Davis TC, Wolf MS, Bass PF 3rd, Thompson JA, Tilson HH, Neuberger M, et al. Literacy and misunderstanding prescription drug labels. Ann Intern Med. 2006;145(12):887–94.PubMedCrossRef
54.
go back to reference Bailey SC, Pandit AU, Yin S, Federman A, Davis TC, Parker RM, et al. Predictors of misunderstanding pediatric liquid medication instructions. Fam Med. 2009;41(10):715–21.PubMed Bailey SC, Pandit AU, Yin S, Federman A, Davis TC, Parker RM, et al. Predictors of misunderstanding pediatric liquid medication instructions. Fam Med. 2009;41(10):715–21.PubMed
55.
go back to reference Jay E, Aslani P, Raynor D. User testing of consumer medicine information in Australia. Health Educ J. 2011;70(4):420–7.CrossRef Jay E, Aslani P, Raynor D. User testing of consumer medicine information in Australia. Health Educ J. 2011;70(4):420–7.CrossRef
56.
go back to reference Communication Research Institute of Australia. Labelling code of practice: designing usable non-prescription medicine labels for consumers. Canberra: Communication Research Press; 2004. p. 19. Communication Research Institute of Australia. Labelling code of practice: designing usable non-prescription medicine labels for consumers. Canberra: Communication Research Press; 2004. p. 19.
57.
go back to reference Division of Nonprescription Clinical Evaluation and the Office of Biostatistics, Center for Drug Evaluation and Research. Guidance for industry: label comprehension studies for nonprescription drug products. U.S.: U.S Department of Health and Human Services Food and Drug Administration; 2010 July. Division of Nonprescription Clinical Evaluation and the Office of Biostatistics, Center for Drug Evaluation and Research. Guidance for industry: label comprehension studies for nonprescription drug products. U.S.: U.S Department of Health and Human Services Food and Drug Administration; 2010 July.
Metadata
Title
Design and comprehensibility of over-the-counter product labels and leaflets: a narrative review
Authors
Vivien Tong
David K. Raynor
Parisa Aslani
Publication date
01-10-2014
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 5/2014
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-014-9975-0

Other articles of this Issue 5/2014

International Journal of Clinical Pharmacy 5/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.